Moderate riskFDA DrugClass II

Merck Emend (aprepitant) oral suspension recalled for potential metal particulates

Merck has recalled a limited lot of Emend (aprepitant) 125 mg oral suspension due to the potential presence of metal particles in the product. This affects 3 single-dose kits with lot number Z014503 and expiration date 11/15/2027 distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have Emend lot Z014503 with expiration 11/15/2027
  2. Do not use this lot if you have it
  3. Contact your pharmacy or doctor for guidance on your prescription
  4. Call Merck at 1-800-672-6372 with questions

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
3 - single dose kits
Illnesses reported
None reported
Manufactured in
4633 Merck Rd W, N/A, Wilson, NC, United States
Classification
Class II
Recall number
D-0241-2026

In the FDA's words

Description
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03 Presence of particulate matter: potential presence of metal particulates in the product. Lot #: Z014503, Exp 11/15/2027 Distribution: Nationwide in the USA Affected quantity: 3 - single dose kits
Hazard
Presence of particulate matter: potential presence of metal particulates in the product.

2 products in this recall

Merck Emend and Noxafil Powdermix recalled for metal particulates

Merck is recalling two prescription medicines, Emend (aprepitant) for oral suspension 125 mg single-dose kits and Noxafil Powdermix (posaconazole) 300 mg packets, because they may contain metal particles. The recall covers 3 Emend kits and 845 Noxafil Powdermix kits, distributed nationwide. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

MetalParticulateDrugsSold nationwideMore from FDA Drug